Ideal Cardiovascular Health Is Inversely Associated with Nonalcoholic Fatty Liver Disease: A Prospective Analysis

被引:31
作者
Wang, Long
Li, Mian
Zhao, Zhiyun
Xu, Min
Lu, Jieli
Wang, Tiange
Chen, Yuhong
Wang, Shuangyuan
Dai, Meng
Hou, Yanan
Wu, Xueyan
Ma, Lina
Li, Lin
Liu, Shanshan
Wang, Weiqing
Xu, Yu
Bi, Yufang
Ning, Guang
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Endocrine & Metab Dis, Natl Clin Res Ctr Metab Dis,Rui Jin Hosp, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Endocrine & Metab Dis, Shanghai, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
Cardiovascular health; Cohori; Nonalcoholic fatty liver disease; Prevention; FIBROSIS SCORE; NAFLD; RISK; PREVALENCE; MORTALITY; PREDICTOR;
D O I
10.1016/j.amjmed.2018.07.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Cardiovascular health has been proven to be associated with major cardiometabolic diseases. However, little is known of associations between cardiovascular health and nonalcoholic fatty liver disease. METHODS: This study included 3424 adults aged >= 40 years who were free of nonalcoholic fatty liver disease at baseline from a community cohort followed for up to 5 years. Liver ultrasonography was conducted at baseline and at follow-up to diagnose incident nonalcoholic fatty liver disease. Six metrics including smoking, physical activity, body mass index, total cholesterol, blood pressure, and fasting glucose were used to define cardiovascular health status. Associations of individual cardiovascular health metrics, number of cardiovascular health metrics, and overall cardiovascular health status at baseline, as well as changes in cardiovascular health during follow-up with risks of developing nonalcoholic fatty liver disease, were examined. RESULTS: A total of 649 participants developed nonalcoholic fatty liver disease during follow-up. Risks of nonalcoholic fatty liver disease reduced in a dose response manner in participants with 3-4 ideal cardiovascular health metrics (odds ratio 0.50; 95% confidence interval, 0.41-0.61) and in participants with 5-6 ideal metrics (odds ratio 0.34; 95% confidence interval 0.22-0.51) compared with participants with 0-2 ideal metrics. An overall ideal or intermediate cardiovascular health was associated with 37% reduction in developing nonalcoholic fatty liver disease compared with poor cardiovascular health. In addition, improving cardiovascular health during follow-up reduced the risk by 71% compared with deteriorating cardiovascular health. Furthermore, an overall ideal or intermediate cardiovascular health was significantly associated with a lower fibrosis score in nonalcoholic fatty liver disease patients compared with an overall poor cardiovascular health. CONCLUSIONS: Ideal cardiovascular health was inversely associated with risks of nonalcoholic fatty liver disease. Although treatment of nonalcoholic fatty liver disease and subsequent inflammation and fibrosis remains a challenge, cardiovascular health goals should be advocated for nonalcoholic fatty liver disease prevention. (C) 2018 Published by Elsevier Inc.
引用
收藏
页码:1515.e1 / 1515.e10
页数:10
相关论文
共 37 条
[1]   Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases [J].
Adams, Leon A. ;
Anstee, Quentin M. ;
Tilg, Herbert ;
Targher, Giovanni .
GUT, 2017, 66 (06) :1138-1153
[2]   The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD [J].
Angulo, Paul ;
Hui, Jason M. ;
Marchesini, Giulio ;
Bugianesi, Ellisabetta ;
George, Jacob ;
Farrell, Geoffrey C. ;
Enders, Felicity ;
Saksena, Sushma ;
Burt, Alastair D. ;
Bida, John P. ;
Lindor, Keith ;
Sanderson, Schuyler O. ;
Lenzi, Marco ;
Adams, Leon A. ;
Kench, James ;
Therneau, Terry M. ;
Day, Christopher P. .
HEPATOLOGY, 2007, 45 (04) :846-854
[3]   Status of Cardiovascular Health in Chinese Adults [J].
Bi, Yufang ;
Jiang, Yong ;
He, Jiang ;
Xu, Yu ;
Wang, Limin ;
Xu, Min ;
Zhang, Mei ;
Li, Yichong ;
Wang, Tiange ;
Dai, Meng ;
Lu, Jieli ;
Li, Mian ;
Chen, Chung-Shiuan ;
Lai, Shenghan ;
Wang, Weiqing ;
Wang, Linhong ;
Ning, Guang .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) :1013-1025
[4]   Human Fatty Liver Disease: Old Questions and New Insights [J].
Cohen, Jonathan C. ;
Horton, Jay D. ;
Hobbs, Helen H. .
SCIENCE, 2011, 332 (6037) :1519-1523
[5]   Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study [J].
Dasarathy, Srinivasan ;
Dasarathy, Jaividhya ;
Khiyami, Amer ;
Joseph, Rajesh ;
Lopez, Rocio ;
McCullough, Arthur J. .
JOURNAL OF HEPATOLOGY, 2009, 51 (06) :1061-1067
[6]   Serum lipoprotein (a) concentrations are inversely associated with T2D, prediabetes, and insulin resistance in a middle-aged and elderly Chinese population [J].
Ding, Lin ;
Song, An ;
Dai, Meng ;
Xu, Min ;
Sun, Wanwan ;
Xu, Baihui ;
Sun, Jichao ;
Wang, Tiange ;
Xu, Yu ;
Lu, Jieli ;
Wang, Weiqing ;
Bi, Yufang ;
Ning, Guang .
JOURNAL OF LIPID RESEARCH, 2015, 56 (04) :920-926
[7]   The American Heart Association Ideal Cardiovascular Health and Incident Type 2 Diabetes Mellitus Among Blacks: The Jackson Heart Study [J].
Effoe, Valery S. ;
Carnethon, Mercedes R. ;
Echouffo-Tcheugui, Justin B. ;
Chen, Haiying ;
Joseph, Joshua J. ;
Norwood, Arnita F. ;
Bertoni, Alain G. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (06)
[8]   Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up [J].
Ekstedt, Mattias ;
Hagstrom, Hannes ;
Nasr, Patrik ;
Fredrikson, Mats ;
Stal, Per ;
Kechagias, Stergios ;
Hultcrantz, Rolf .
HEPATOLOGY, 2015, 61 (05) :1547-1554
[9]   New trends on obesity and NAFLD in Asia [J].
Fan, Jian-Gao ;
Kim, Seung-Up ;
Wong, Vincent Wai-Sun .
JOURNAL OF HEPATOLOGY, 2017, 67 (04) :862-873
[10]   Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: Executive summary [J].
Farrell, Geoffrey C. ;
Chitturi, Shivakumar ;
Lau, George K. K. ;
Sollano, Jose D. .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (06) :775-777